1. Patient-Centered Management in Pancreatic Cancer

2. Activity Goals

3. Case Study 1: First-Line Therapy for Advanced Pancreatic Cancer

5. ACCORD Study: FOLFIRINOX vs Gemcitabine

7. Common AEs With Frontline Treatment of Pancreatic Cancer

8. Considerations When Selecting Therapies

9. Case Study 2: Progression on First-Line Therapy

10. Select Salvage Therapy Regimens

11. NAPOLI-1 Study: Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid

12. NAPOLI-1 Study: Results

13. Educating and Communicating With Patients

14. Key Takeaways for Advanced/Metastatic Pancreatic Cancer

15. Key Takeaways for Advanced/Metastatic Pancreatic Cancer (cont)

16. Abbreviations